A positive correlation is observed between VISTA expression in the immune cells of patients with bladder cancer, including non-muscle invasive bladder cancer, and clinicopathological features such as tumor grade, stage, size, and multiplicity (84). Here, VSIR is linked to urinary bladder carcinoma.